Federal Register of Legislation - Australian Government

Primary content

PB 45 of 2012 Determinations/Health as made
This determination amends the National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) to add one new brand premium, remove three brands that no longer have a brand premium and provide the increases and decreases of brand premiums to other brands of pharmaceutical items.
Administered by: Health
Registered 25 Jul 2012
Tabling HistoryDate
Tabled HR14-Aug-2012
Tabled Senate14-Aug-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 45 of 2012

National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 4)1

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 19 July 2012

 

 

 

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 4).

            (2)        This Instrument may also be cited as PB 45 of 2012.

2          Commencement

            This Instrument commences on 1 August 2012.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

[1]       Schedule 1, entry for Alendronic Acid

omit from the column headed “Claimed Price”:          20.13     substitute:             20.52

[2]       Schedule 1, entry for Alprazolam in the form Tablet 250 micrograms

omit from the column headed “Claimed Price”:          2.86        substitute:             3.84

[3]       Schedule 1, entry for Alprazolam in the form Tablet 500 micrograms

omit from the column headed “Claimed Price”:          4.22        substitute:             5.16

[4]       Schedule 1, entry for Alprazolam in the form Tablet 1 mg

omit from the column headed “Claimed Price”:          6.93        substitute:             7.72

[5]       Schedule 1, entry for Alprazolam in the form Tablet 2 mg

omit from the column headed “Claimed Price”:          10.43     substitute:             11.04

[6]       Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)

omit from the column headed “Claimed Price”:          6.05        substitute:             7.64

[7]       Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)

omit from the column headed “Claimed Price”:          10.11     substitute:             12.46

[8]       Schedule 1, entry for Aspirin

(a)           omit from the column headed “Determined Price”:     1.40        substitute:             1.18

(b)           omit from the column headed “Claimed Price”:          2.52        substitute:             2.12

[9]       Schedule 1, entry for Captopril in the form Tablet 25 mg

omit from the column headed “Claimed Price”:          13.89     substitute:             16.40

[10]     Schedule 1, entry for Captopril in the form Tablet 50 mg

omit from the column headed “Claimed Price”:          23.98     substitute:             25.16

[11]     Schedule 1, entry for Cefaclor in the form Tablet (sustained release) 375 mg (as monohydrate)

omit from the column headed “Claimed Price”:          7.69        substitute:             9.63

[12]     Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          5.75        substitute:             7.20

[13]     Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

omit from the column headed “Claimed Price”:          6.09        substitute:             7.63

[14]     Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)

omit from the column headed “Claimed Price”:          3.07        substitute:             4.73

[15]     Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)

omit from the column headed “Claimed Price”:          4.70        substitute:             7.24

[16]     Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          3.46        substitute:             5.32

[17]     Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL

omit from the column headed “Claimed Price”:          4.65        substitute:             7.16

[18]     Schedule 1, entry for Citalopram

omit from the column headed “Claimed Price”:          7.86        substitute:             9.99

[19]     Schedule 1, entry for Codeine with Paracetamol

omit from the column headed “Claimed Price”:          2.56        substitute:             3.36

[20]     Schedule 1, omit entry for Cyclosporin

[21]     Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Androcur, Quantity or Number of Units 20]

(a)           omit from the column headed “Determined Price”:     39.73     substitute:             33.37

(b)           omit from the column headed “Claimed Price”:          42.70     substitute:             35.87


[22]     Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Androcur, Quantity or Number of Units 50]

(a)           omit from the column headed “Determined Price”:     87.07     substitute:             73.14

(b)           omit from the column headed “Claimed Price”:          88.49     substitute:             74.33

[23]     Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg

(a)           omit from the column headed “Determined Price”:     141.07   substitute:             118.50

(b)           omit from the column headed “Claimed Price”:          142.49   substitute:             119.69

[24]     Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          3.84        substitute:             3.91

[25]     Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          3.96        substitute:             4.29

[26]     Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Doryx, Quantity or Number of Units 7]

omit from the column headed “Claimed Price”:          2.64        substitute:             4.17

[27]     Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Doryx, Quantity or Number of Units 21]

omit from the column headed “Claimed Price”:          6.76        substitute:             8.43

[28]     Schedule 1, entry for Doxycycline in the form Tablet 50 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          4.05        substitute:             4.70

[29]     Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)

omit from the column headed “Claimed Price”:          4.09        substitute:             5.54

[30]     Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg

omit from the column headed “Claimed Price”:          6.91        substitute:             7.93

[31]     Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg

omit from the column headed “Claimed Price”:          9.42        substitute:             10.43

[32]     Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg

omit from the column headed “Claimed Price”:          11.16     substitute:             12.17

[33]     Schedule 1, entry for Erythromycin in the form Capsule 250 mg (containing enteric coated pellets)

omit from the column headed “Claimed Price”:          5.78        substitute:             6.24

[34]     Schedule 1, entry for Frusemide in the form Tablet 20 mg

omit from the column headed “Claimed Price”:          1.60        substitute:             1.74

[35]     Schedule 1, entry for Frusemide in the form Tablet 40 mg

omit from the column headed “Claimed Price”:          3.39        substitute:             3.74

[36]     Schedule 1, entry for Gabapentin in the form Capsule 100 mg

omit from the column headed “Claimed Price”:          10.82     substitute:             11.92

[37]     Schedule 1, entry for Gabapentin in the form Capsule 300 mg

omit from the column headed “Claimed Price”:          34.78     substitute:             36.12

[38]     Schedule 1, entry for Gabapentin in the form Capsule 400 mg

omit from the column headed “Claimed Price”:          47.22     substitute:             48.37

[39]     Schedule 1, entry for Gabapentin in the form Tablet 600 mg

omit from the column headed “Claimed Price”:          74.59     substitute:             75.75

[40]     Schedule 1, entry for Gabapentin in the form Tablet 800 mg

omit from the column headed “Claimed Price”:          99.23     substitute:             100.39

[41]     Schedule 1, entry for Glimepiride in the form Tablet 1 mg

omit from the column headed “Claimed Price”:          3.41        substitute:             4.06

[42]     Schedule 1, entry for Glimepiride in the form Tablet 2 mg

omit from the column headed “Claimed Price”:          4.91        substitute:             5.56

[43]     Schedule 1, entry for Glimepiride in the form Tablet 3 mg

omit from the column headed “Claimed Price”:          5.76        substitute:             6.42

[44]     Schedule 1, entry for Glimepiride in the form Tablet 4 mg

omit from the column headed “Claimed Price”:          6.66        substitute:             7.30

[45]     Schedule 1, entry for Hypromellose with Dextran

omit from the column headed “Claimed Price”:          5.08        substitute:             5.31

[46]     Schedule 1, entry for Indapamide

(a)           omit from the column headed “Determined Price”:     9.14        substitute:             7.68

(b)           omit from the column headed “Claimed Price”:          11.25     substitute:             9.45

[47]     Schedule 1, omit entry for Isotretinoin

[48]     Schedule 1, after entry for Lamotrigine in the form Tablet 200 mg

insert in the columns in the order indicated:

Lansoprazole

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

14.81

15.64

[49]     Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Prinivil 5]

omit from the column headed “Claimed Price”:          7.32        substitute:             8.00

[50]     Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Prinivil 10]

omit from the column headed “Claimed Price”:          9.69        substitute:             10.40

[51]     Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Prinivil 20]

omit from the column headed “Claimed Price”:          11.54     substitute:             12.24

[52]     Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 5 mg

omit from the column headed “Claimed Price”:          8.62        substitute:             8.89

[53]     Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg
[Provera, Quantity or Number of Units 30]

omit from the column headed “Claimed Price”:          9.15        substitute:             9.42


[54]     Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg
[Provera, Quantity or Number of Units 100]

omit from the column headed “Claimed Price”:          22.44     substitute:             22.81

[55]     Schedule 1, entry for Methyldopa

(a)           omit from the column headed “Determined Price”:     5.98        substitute:             6.48

(b)           omit from the column headed “Claimed Price”:          8.16        substitute:             8.83

[56]     Schedule 1, entry for Methylprednisolone

omit from the column headed “Claimed Price”:          13.53     substitute:             13.84

[57]     Schedule 1, entry for Mirtazapine in the form Tablet 30 mg

omit from the column headed “Claimed Price”:          15.12     substitute:             15.90

[58]     Schedule 1, entry for Mirtazapine in the form Tablet 45 mg

omit from the column headed “Claimed Price”:          23.92     substitute:             24.50

[59]     Schedule 1, entry for Norfloxacin

omit from the column headed “Claimed Price”:          8.69        substitute:             9.77

[60]     Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 20 mg

omit from the column headed “Claimed Price”:          10.37     substitute:             11.24

[61]     Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg

omit from the column headed “Claimed Price”:          21.04     substitute:             21.91

[62]     Schedule 1, entry for Paraffin in the form Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

omit from the column headed “Claimed Price”:          7.39        substitute:             7.55

[63]     Schedule 1, entry for Piroxicam in the form Dispersible tablet 20 mg

omit from the column headed “Claimed Price”:          6.95        substitute:             7.35

[64]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg

omit from the column headed “Claimed Price”:          7.97        substitute:             9.74

[65]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg

omit from the column headed “Claimed Price”:          11.70     substitute:             13.43

[66]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg

omit from the column headed “Claimed Price”:          17.59     substitute:             19.19

[67]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg

omit from the column headed “Claimed Price”:          25.70     substitute:             27.51

[68]     Schedule 1, entry for Prednisolone in the form Oral solution 5 mg (as sodium phosphate) per mL, 30 mL

omit from the column headed “Claimed Price”:          8.74        substitute:             9.25

[69]     Schedule 1, entry for Quinapril in the form Tablet 5 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          5.01        substitute:             6.41

[70]     Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          7.13        substitute:             8.42

[71]     Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          8.95        substitute:             10.02

[72]     Schedule 1, entry for Roxithromycin in the form Tablet 150 mg

omit from the column headed “Claimed Price”:          4.39        substitute:             5.17

[73]     Schedule 1, entry for Roxithromycin in the form Tablet 300 mg

omit from the column headed “Claimed Price”:          4.39        substitute:             5.17

[74]     Schedule 1, entry for Sertraline in the form Tablet 50 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          8.92        substitute:             9.95

[75]     Schedule 1, entry for Sertraline in the form Tablet 100 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          8.92        substitute:             9.95

[76]     Schedule 1, entry for Simvastatin in the form Tablet 5 mg

omit from the column headed “Claimed Price”:          6.47        substitute:             7.83

[77]     Schedule 1, entry for Simvastatin in the form Tablet 10 mg

omit from the column headed “Claimed Price” (twice occuring):            8.36        substitute:             9.72

[78]     Schedule 1, entry for Simvastatin in the form Tablet 20 mg

omit from the column headed “Claimed Price” (twice occuring):            11.36     substitute:             12.70

[79]     Schedule 1, entry for Simvastatin in the form Tablet 40 mg

omit from the column headed “Claimed Price” (twice occuring):            15.90     substitute:             17.03

[80]     Schedule 1, entry for Simvastatin in the form Tablet 80 mg

omit from the column headed “Claimed Price” (twice occuring):            21.92     substitute:             23.21

[81]     Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg

omit from the column headed “Claimed Price”:          8.48        substitute:             9.86

[82]     Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg

omit from the column headed “Claimed Price”:          14.78     substitute:             16.17

[83]     Schedule 1, entry for Temazepam

omit from the column headed “Claimed Price”:          1.96        substitute:             2.69

[84]     Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg

omit from the column headed “Claimed Price”:          3.30        substitute:             3.81

[85]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg

omit from the column headed “Claimed Price”:          7.60        substitute:             8.56

[86]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg

omit from the column headed “Claimed Price”:          9.79        substitute:             10.93

[87]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg

omit from the column headed “Claimed Price”:          11.61     substitute:             12.91

[88]     Schedule 1, entry for Trandolapril in the form Capsule 2 mg

omit from the column headed “Claimed Price”:          7.23        substitute:             8.62

[89]     Schedule 1, entry for Trandolapril in the form Capsule 4 mg

omit from the column headed “Claimed Price”:          12.51     substitute:             13.89

[90]     Schedule 1, entry for Verapamil in the form Tablet containing verapamil hydrochloride 180 mg (sustained release)

omit from the column headed “Claimed Price”:          7.90        substitute:             9.07

[91]     Schedule 1, entry for Verapamil in the form Tablet containing verapamil hydrochloride 240 mg (sustained release)

omit from the column headed “Claimed Price”:          9.91        substitute:             11.09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.